Point72 Asset Management disclosed a 5.3% stake in Pulmonx, which represents over 1.97M shares. The filing does not allow for activism.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on LUNG:
- BofA downgrades Pulmonx to Underperform on limited upside potential
- Pulmonx downgraded to Underperform from Neutral at BofA
- Pulmonx upgraded to Buy from Neutral at Citi
- Pulmonx announces Japan regulators approve Zephyr Endobronchial Valve for COPD
- Pulmonx to Present at the 34th Annual Piper Sandler Healthcare Conference